Kiniksa Pharmaceuticals International (KNSA) shares outstanding

Shares outstanding · fiscal 2025
78.98M

Kiniksa Pharmaceuticals International (KNSA) had 78.98M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 10.6% higher than the 71.42M of fiscal 2024. Figures as of 18 Nov 2026, 12:13 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
78.98M
Change on fiscal 2024
+10.6%
Growth, 5 years
+5.0% a year
Highest on record
78.98Mfiscal 2025
Lowest on record
54.05Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Kiniksa Pharmaceuticals International shares outstanding, in more detail

The market data feed counts 48.84M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 5.0% a year. Across the 7 fiscal years on record (2019–2025), the highest was 78.98M in fiscal 2025 and the lowest 54.05M in fiscal 2019.

History · 7 fiscal years

Shares outstanding by fiscal year

Kiniksa Pharmaceuticals International shares outstanding, year by year

Kiniksa Pharmaceuticals International (KNSA) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202578.98M 10.6% up
202471.42M 0.7% down
202371.92M 2.1% up
202270.42M 2.7% up
202168.58M 10.9% up
202061.84M 14.4% up
201954.05M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Kiniksa Pharmaceuticals International and comparable companies
CompanyShares outstandingFiscal year
Kiniksa Pharmaceuticals International KNSA78.98M2025
ABIVAX ABVX69.53M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on KNSA

Kiniksa Pharmaceuticals International, figure by figure

Kiniksa Pharmaceuticals International (KNSA) overview: price, valuation and scorecardAll health care companies by market value

Kiniksa Pharmaceuticals International shares outstanding: questions and answers

How many shares does Kiniksa Pharmaceuticals International have?

Kiniksa Pharmaceuticals International (KNSA) had 78.98M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 10.6% higher than the 71.42M of fiscal 2024. The market data feed counts 48.84M shares outstanding today.

What is the growth rate of Kiniksa Pharmaceuticals International's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 5.0% a year.

What are the highest and lowest diluted share count figures on record for Kiniksa Pharmaceuticals International?

Across the 7 fiscal years on record (2019–2025), the highest was 78.98M in fiscal 2025 and the lowest 54.05M in fiscal 2019.

How is Kiniksa Pharmaceuticals International's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Kiniksa Pharmaceuticals International it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Kiniksa Pharmaceuticals International (KNSA) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/KNSA/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.